Koschmieder, S., Schulte, C., Heyde, E. v. d., Busque, L., Boyer-Perrard, F., Devos, T., . . . Harrison, C. (2025). Clinical outcomes of high-risk patients with polycythemia vera after suboptimal response to first-line therapy who switched to ruxolitinib versus nonswitchers: Results from the PV-Switch study. SAGE Publishing.
Chicago Style (17th ed.) CitationKoschmieder, Steffen, et al. Clinical Outcomes of High-risk Patients with Polycythemia Vera After Suboptimal Response to First-line Therapy Who Switched to Ruxolitinib Versus Nonswitchers: Results from the PV-Switch Study. SAGE Publishing, 2025.
MLA (9th ed.) CitationKoschmieder, Steffen, et al. Clinical Outcomes of High-risk Patients with Polycythemia Vera After Suboptimal Response to First-line Therapy Who Switched to Ruxolitinib Versus Nonswitchers: Results from the PV-Switch Study. SAGE Publishing, 2025.